HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical relevance of Elf-1 overexpression in endometrial carcinoma.

AbstractOBJECTIVES:
Elf-1 is a member of the Ets transcription factor family that regulates the genes involved in cellular growth and differentiation. Enhanced expression of Elf-1 has been reported in prostate cancer, breast cancer, and osteosarcoma.
METHODS:
To elucidate the involvement of Elf-1 in endometrial carcinogenesis, we analyzed serial frozen tissue sections from 31 patients with endometrial carcinoma and 20 patients with normal endometria for Elf-1 protein expression, using fluorescent immunohistochemistry. We analyzed the relationship between the percentages of Elf-1-stained cells and patient characteristics, including clinical stage, histological grade, presence of invasion to greater than one-half the myometrium, clinical outcome, and survival rate.
RESULTS:
Elf-1 was weakly detected in some normal endometria in the proliferative phase (0-18.9%) and other normal endometria in the secretory phase (0-28.5%). There was, however, abundant Elf-1 immunoreactivity in the nucleus of the endometrial carcinoma cells along with a little cytoplasmic staining. Scoring on the basis of the percentage of nuclear-positive cells indicated that nuclear Elf-1 expression was significantly associated with PCNA-labeling index, clinical stage, histological grade, the presence of invasion to greater than one-half the myometrium, and clinical outcome (P < 0.01, respectively). Survival data were available for all patients and demonstrated that Elf-1 expression was significantly associated with poor prognosis (P < 0.01).
CONCLUSIONS:
Our results demonstrate that Elf-1 expression in endometrial carcinoma correlates with the malignant potential of this tumor.
AuthorsNoriyuki Takai, Tami Miyazaki, Masakazu Nishida, Sujie Shang, Kaei Nasu, Isao Miyakawa
JournalGynecologic oncology (Gynecol Oncol) Vol. 89 Issue 3 Pg. 408-13 (Jun 2003) ISSN: 0090-8258 [Print] United States
PMID12798703 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA-Binding Proteins
  • Proliferating Cell Nuclear Antigen
  • Transcription Factors
Topics
  • DNA-Binding Proteins (biosynthesis, metabolism)
  • Endometrial Neoplasms (metabolism, pathology)
  • Female
  • Humans
  • Neoplasm Invasiveness
  • Neoplasm Staging
  • Prognosis
  • Proliferating Cell Nuclear Antigen (metabolism)
  • Transcription Factors (biosynthesis, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: